Structure of macrophage migration inhibitory factor in complex with methotrexate.

Kei Fukushima, Minoru Furuya, Takashi Kamimura, Midori Takimoto-Kamimura

Acta crystallographica. Section D, Structural biology 2021 Mar 01

filter terms:

Methotrexate (MTX) is an anticancer and anti-rheumatoid arthritis drug that is considered to block nucleotide synthesis and the cell cycle mainly by inhibiting the activity of dihydrofolate reductase (DHFR). Using affinity-matrix technology and X-ray analysis, the present study shows that MTX also interacts with macrophage migration inhibitory factor (MIF). Fragment molecular-orbital calculations quantified the interaction between MTX and MIF based on the structure of the complex and revealed the amino acids that are effective in the interaction of MTX and MIF. It should be possible to design new small-molecule compounds that have strong inhibitory activity towards both MIF and DHFR by structure-based drug discovery.

Citation

Kei Fukushima, Minoru Furuya, Takashi Kamimura, Midori Takimoto-Kamimura. Structure of macrophage migration inhibitory factor in complex with methotrexate. Acta crystallographica. Section D, Structural biology. 2021 Mar 01;77(Pt 3):293-299